DNA vs TYRA

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 11, 2026

DNA

38.5
AI Score
VS
TYRA Wins

TYRA

55.6
AI Score

Investment Advisor Scores

DNA

39score
Recommendation
EXTENDED

TYRA

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric DNA TYRA Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth -48.5% 0.0% TYRA
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 38.5/100 55.6/100 TYRA
Profit Margin -219.6% 0.0% TYRA
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED HOLD Tie

Relative Price Performance (Last 90 Days)

DNA 1M: -4.1% · 3M: +31.9% TYRA 1M: -8.9% · 3M: -34.3%

Current Technical Phase

DNA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 46.3 · Price: $9.83

TYRA

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 45

RSI (14): 45.1 · Price: $20.42

Fundamentals Snapshot

Metric DNA TYRA
Market Cap — —
Forward P/E -3.4 -7.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth -0.5% 0.0%
Gross Margin 0.7% —
Operating Margin -2.8% 0.0%
EPS -5.06 -2.39
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TYRA is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.